Trivalent and Pentavalent Antimonials Impair Cardiac Mitochondrial Function in Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26189073 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Itanna Isis Araujo de Souza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil. Hauptthemen laut MEDLINE: Mitochondria, Heart, Antimony, Antiprotozoal Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Funda̧cão Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundação Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).
Abstract (Originalsprache)
Pentavalent sodium antimoniate (Sb(V)) has been used for over 50 years in leishmaniasis treatment. Sb(V) is converted into trivalent antimony (Sb(III)) within macrophages acting as a prodrug by disrupting fatty acid beta-oxidation and glycolysis, impairing the energy metabolism of the parasite. Despite extensive use, the effects of antimonials on host mitochondria are not well understood. This study investigated the impact of Sb(V) and Sb(III) on mitochondria isolated from mouse hearts via differential centrifugation and lastly incubated with Sb(V) or Sb(III). Mitochondrial function was evaluated by oxygen consumption, ATP production, reactive oxygen species (ROS) generation, and transmembrane potential. Both Sb(V) and Sb(III) reduced oxygen consumption in complex I respiratory states 1, 2, and 3 at 1 µg/mL and 1 ng/mL. ROS production increased in Sb(V)-treated mitochondria. ATP production was impaired by both drugs starting at 1 ng/mL. Proton leak also increased, and significant changes in transmembrane potential were observed at both concentrations. These findings indicate that Sb(V) and Sb(III) directly compromise mitochondrial function from isolated mouse heart mitochondria by reduced ATP production and increased ROS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.
- Programa de Pós-Graduação em Cardiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-617, RJ, Brazil.
- Campus Professor Geraldo Cidade, Universidade Federal do Rio de Janeiro, Duque de Caxias 25240-005, RJ, Brazil.
ORCID-Profile: Caroline da Silva Moraes, José Hamilton Matheus Nascimento, Antonio Carlos Campos de Carvalho, Leonardo Maciel
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Funda̧cão Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
- Fundação Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
Zitieren
APA
Souza, I. I. A., Pavarino, M. E. M. F., Rosa, C. F. M. D., Marinho, L. E., Moraes, C. D. S., Nascimento, J. H. M., Carvalho, A. C. C., & Maciel, L. (2025). Trivalent and Pentavalent Antimonials Impair Cardiac Mitochondrial Function in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189073
Vancouver
Souza IIA, Pavarino MEMF, Rosa CFMD, Marinho LE, Moraes CDS, Nascimento JHM, et al. Trivalent and Pentavalent Antimonials Impair Cardiac Mitochondrial Function in Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189073
BibTeX
@article{Souza2025,
author = {Souza, Itanna Isis Araujo de and Pavarino, Maria Eduarda Maciel Fernandes and Rosa, César Francisco Maricato da and Marinho, Laís Eduardo and Moraes, Caroline da Silva and Nascimento, José Hamilton Matheus and Carvalho, Antonio Carlos Campos de and Maciel, Leonardo},
title = {Trivalent and Pentavalent Antimonials Impair Cardiac Mitochondrial Function in Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26189073}
}
EUVIMED